| For: | Kumar R, Kumar A, Kumar S. Acute liver failure from anti-tuberculosis drug-induced liver injury: An update. World J Hepatol 2025; 17(5): 106618 [PMID: 40501479 DOI: 10.4254/wjh.v17.i5.106618] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i5/106618.htm |
| Number | Citing Articles |
| 1 |
Juan C. Polo, Jesus M. Angulo-Mercado, Sandra M. Coronado-Ríos, Fernando de la Vega, Edwin D. Correa, Nelson E. Arenas. Dynamic Biochemical Phenotypes in Hospitalized Patients with Pulmonary Tuberculosis. Sci 2026; 8(2): 35 doi: 10.3390/sci8020035
|
| 2 |
Abhishek Kumar, Ramesh Kumar, Vijay Kumar, Sudhir Kumar, Sudheer Marrapu, Utpal Anand, Rajeev N. Priyadarshi. Patterns of Liver Injury and Adaptation in Patients With Abdominal Tuberculosis on Antituberculosis Treatment: A Prospective Cohort Study. Journal of Clinical and Experimental Hepatology 2025; 15(6): 103124 doi: 10.1016/j.jceh.2025.103124
|
| 3 |
Tomislava Skuhala, Anja Dragobratović, Luka Marinković, Kristina Ramljak, Marin Rimac, Arijana Pavelić, Snjezana-Zidovec Lepej. Antitubercular Drug-Induced Liver Injury in the Treatment of Tuberculous Lymphadenitis: A Comprehensive Review. Livers 2026; 6(2): 19 doi: 10.3390/livers6020019
|
| 4 |
Yurou Li, Zhenzhen Yan, Wanrong Zhang, Xin Zheng, Zhengping Wu, Yinjie Jiang, Jie Zhou. Sodium aescinate induces hepatocyte ferroptosis through the Nrf2/PRDX6/GPX4 axis. Archives of Biochemistry and Biophysics 2026; 781: 110826 doi: 10.1016/j.abb.2026.110826
|
| 5 |
Irene Díaz-Alberola, Daniel E. Di Zeo-Sánchez, Vanesa Garrido-Rodríguez, Carlos López-Gómez, Cristina Rodríguez-Díaz, Raul J. Andrade, M. Isabel Lucena, Marina Villanueva-Paz, Eduardo García-Fuentes. The gut–liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system. Acta Pharmaceutica Sinica B 2026; doi: 10.1016/j.apsb.2026.04.014
|